Arnaud Pigneux

9PUBLICATIONS
96CO-AUTHORS
Liquid biopsiesMedical infection agents (incl. prions)Medical mycologyMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Sep 25, 2025
Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.

Eunice S Wang, Pau Montesinos, James Foran

|Aug 21, 2025
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.

Jules Higué, Corentin Orvain, Pierre-Yves Dumas

|Mar 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

Vinod Pullarkat, Keith W Pratz, Hartmut Döhner

Pageof 2

Frequent Collaborators

5 joint publications

Christian Recher

4 joint publications

Audrey Bidet

4 joint publications

Sarah Bertoli

3 joint publications

Pierre-Yves Dumas